𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure of beta interferon therapy in X-linked adrenoleukodystrophy

✍ Scribed by G. C. Korenke; H. -J. Christen; D. H. Hunneman; F. Hanefeld


Publisher
Springer
Year
1996
Tongue
English
Weight
377 KB
Volume
155
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Therapy of X-linked adrenoleukodystrophy
✍ Moser, Hugo W. πŸ“‚ Article πŸ“… 2006 πŸ› American Society for Experimental NeuroTherapeutic 🌐 English βš– 88 KB
Epidemiology of X-linked adrenoleukodyst
✍ Y. Takemoto; Y. Suzuki; A. Tamakoshi; O. Onodera; S. Tsuji; T. Hashimoto; N. Shi πŸ“‚ Article πŸ“… 2002 πŸ› Nature Publishing Group 🌐 English βš– 206 KB
Thrombocytopenia induced by erucic acid
✍ Zierz, S. ;SchrοΏ½der, R. ;Unkrig, C.J. πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 401 KB

Five patients with various clinical and genetic phenotypes of adrenoleukodystrophy were treated with a diet enriched with glycerol trioleate and glycerol trierucate (GTE). In all patients platelet counts decreased upon the administration of GTE, but no bleeding symptoms occurred in any of the patien

The cystathionine beta-synthase variant
✍ Michael Linnebank; Alexander Semmler; Wim J. Kleijer; Marianne L.T. van der Ster πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 213 KB

The clinical course of X-linked adrenoleukodystrophy (X-ALD) is of unexplained heterogeneity. Major X-ALD phenotypes are the progressive childhood cerebral form (CCALD) with early confluent cerebral demyelination and the adult-onset adrenomyeloneuropathy (AMN). Adult AMN may present with demyelinate

Targeted inactivation of the X-linked ad
✍ Sonja Forss-Petter; Hauke Werner; Johannes Berger; Hans Lassmann; Brunhilde Molz πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 1021 KB

In its severe form, X-linked adrenoleukodystrophy (ALD) is a lethal neurologic disease of children, characterized by progressive cerebral demyelination and adrenal insufficiency. Associated with a biochemical defect of peroxisomal ␀-oxidation, very long-chain fatty acids (VLCFA) build up in tissues